Study Type
Interventional - Drug
PACIFIC-Stroke was a randomized, placebo controlled, double-blind, parallel group, dose-finding Phase 2 study to evaluate efficacy and safety of BAY 2433334 in patients following an acute non-cardioembolic ischemic stroke.
Primary outcome measures:
Interventional - Drug
Randomized placebo controlled double-blind parallel group phase 2
25
250
1800
2020 - 2022
Bayer
Back To Top